Drug intelligence / Profile preview

lipohydroxyacid + salicylic acid

Development stage
Unknown
Lead developer
L'Oréal
Modality
Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

This is a topical combination of two exfoliating agents—lipohydroxyacid (LHA) and salicylic acid—used primarily in dermatological skincare products for the treatment of acne and improvement of skin texture. Lipohydroxyacid (also known as capryloyl salicylic acid or 2-hydroxy-5-octanoyl benzoic acid) is a derivative of salicylic acid with an added fatty chain, making it more lipophilic and allowing for slower, more targeted exfoliation at the skin surface. Salicylic acid is a beta hydroxy acid that penetrates into pores to dissolve sebum and dead skin cells, providing comedolytic (anti-blackhead/whitehead) effects. The combination leverages both rapid pore penetration from salicylic acid and gentle surface renewal from LHA. Clinical studies have shown that formulations containing both ingredients improve acne severity, reduce comedones, enhance skin tone evenness, decrease post-inflammatory erythema/hyperpigmentation (PIE/PIH), regulate sebum secretion, and increase hydration without significant irritation[1][2][3][5]. LHA was originally developed by L'Oréal researchers in the 1980s[1].

Other names
LHA + salicylic acidlipo-hydroxy acid + salicylic acidcapryloyl salicylic acid + salicylic acid

Beyond the preview

Go deeper on lipohydroxyacid + salicylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lipohydroxyacid + salicylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call